Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
FDA Introduces Cybersecurity Modernization Plan to Prevent Hacking of Medical Devices A growing rise in cybersecurity hacking attempts have been identified since the beginning of the COVID-19 pandemic, leading to increased attention on preventative measures November 21, 2022 Luke Tollen Add Your Comments Federal regulators have released a new series of cybersecurity enhancements, which are designed to prevent hacking of medical devices, by adopting a “Zero Trust” rule. The U.S. Food and Drug Administration (FDA) and the Office of Digital Transformation (ODT) announced the Cybersecurity Modernization Action Plan (CMAP) on November 17, as part of an ongoing effort to reduce the growing risk of medical devices being hacked due to security vulnerabilities. Cybersecurity threats in the medical field have been a growing concern over the last few years, as vulnerabilities to healthcare organizations’ record systems and medical devices have surfaced. During the pandemic, the FDA warned that there was an increase in reconnaissance activities, denial of service, attempted exploitation, and other cyber issues against the digital infrastructure. The agency reported a 457% increase in issues which include almost 10 billion firewall and intrusion blocks monthly. The agency indicates this increase in hacking attempts poses a significant threat to its operations of a global technology enterprise. Therefore, the FDA announced it will continue to leverage innovative tools and technologies like machine learning, AI, data sharing, collaboration platforms, and high-performance computing. To further combat cybersecurity threats, the FDA and ODT are adopting a Zero Trust strategy which aims to only grant authorized personnel with access to necessary information. Officials stated this approach will limit the ways in which information can be intercepted or released. The key elements outlined in the Cybersecurity Modernization Action Plan include: Establish a comprehensive Zero Trust approach to facilitate new digital services and modernization efforts. Promote software assurance best practices that include security measures at every stage of the development lifecycle Enhance interoperable and secure data exchange, and collaboration across FDA and its public health partners. Leverage Artificial Intelligence/Machine Learning (AI/ML) technologies to enhance cyber detection and response capabilities. Integrate counterintelligence and insider risk principles with the Zero Trust model to enable an intelligence driven approach. Prioritize and invest in FDA’s cybersecurity workforce. The plan is to create a high-skilled cyber workforce with the latest technology and processes to adapt to the modern cybersecurity landscape, officials said. The cybersecurity threats endanger many different parts of people’s lives, including their medical health. Since 2019, the FDA has taken actions against cybersecurity attacks with its releases of the Technology Modernization Action Plan (TMAP), Data Modernization Action Plan (DMAP) in 2021, and Enterprise Modernization Action Plan (EMAP) this year. Medical Device Cybersecurity Attacks Since 2014, the U.S. Department of Homeland Security (DHS) has been actively investigating at least two dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment. According to DHS, if preventative actions to strengthen the medical field’s cybersecurity issues are not taken, hackers could exploit these vulnerabilities and put patients in serious risk. The FDA issued a cybersecurity warning on September 20, alerting medical device users that the Medtronic MiniMed 600 Series Insulin Pump System has a communication protocol that could allow unauthorized use. The agency warned this exploit could be used to cause the pumps to deliver too much, or too little, insulin, which could prove fatal. MEDTRONIC MINIMED LAWSUITS Did you or a loved one receive a Medtronic MiniMed insulin pump? Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION MEDTRONIC MINIMED LAWSUITS Did you or a loved one receive a Medtronic MiniMed insulin pump? Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION This warning came after a previous one made in March 2019 regarding vulnerabilities with Medtronic ICDs or cardiac resynchronization therapy defibrillators (CRT-Ds), after discovering the wireless telemetry system used to communicate and alter the implanted devices could be hacked due to a lack of security protocols. Other announcements have been made over the past few years similar to the Medtronic MiniMed issues. The Department of Homeland Security (DHS) and the FDA released a medical device cybersecurity warning, titled “URGENT/11”, on October 1, 2019, which detailed how certain medical devices that communicate over a network may contain vulnerabilities, potentially allowing hackers to remotely take control of the device and change its functions. Tags: Cybersecurity, Medical Device More Medtronic MiniMed Lawsuit Stories Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks October 7, 2024 FDA Issues “Do Not Use” Warning for Recalled Medtronic NIM Endotracheal Tubes July 10, 2024 Medfusion Syringe Pump Recall Issued Over Software Errors March 6, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: yesterday) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 2 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 3 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: yesterday) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 2 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 3 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)